DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
Transcript of DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
1/118
Sandy Kanehl, M.Ed., CSAC, Mid-Atlantic ATTC
April 26, 2012, Charleston, WV
Overview of Substance Use Disorders
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
2/118
Your Mid-Atlantic Addiction Technology Transfer Center
serves West Virginia, KY, TN, and VA
VCU
We are located at
Virginia Commonwealth
University
http://www.attcnetwork.org/regcenters/indexmidatlantic.asp
http://www.attcnetwork.org/regcenters/indexmidatlantic.aspmailto:[email protected]:[email protected]://www.attcnetwork.org/regcenters/indexmidatlantic.asp -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
3/118
Our objectives today: Learn current info on drugs of abuse,
trends, prevalence, basic addiction science Understand proposed changes for SUD Dx
in DSM-V
Identify new trends in the fieldRM, ROS,
impact of HCR
Discuss implications of theabove for clinical practice
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
4/118
Whos here?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
5/118
Context
What are the most stigmatized
illnesses in our culture? How does the public view
substance misuse/people
with SUDs? How do professionals view
people with SUDs?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
6/118
One more context slide How many of us personally know someone who
has struggled with SUD?
know someone who has tried but could not access
services? Why?
know someone whos been administratively
discharged from Tx for exhibiting the Sx of the illness
for which they are being treated?
What is the general publics view of
addiction treatment?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
7/118
Drugs of abuse, trends, prevalence, basic addictionscience
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
8/118
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
9/118
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
10/118
Emerging Drugs K2/Spice
diverse family of herbal mixtures marketed under many names, including fakemarijuana, Yucatan Fire, Skunk, Moon Rocks, and others. Products contain dried,
shredded plant material and presumably, chemical additives that are responsible fortheir psychoactive effects. Sold in head shops, gas stations, and via the Internet
Salvia herb with main active ingredient salvinorin A, a potent activator of kappa opioid
receptors in the brain; different receptors from the commonly known opioids, such asheroin and morphine. Ingested by chewing fresh leaves or by drinking their juices. Driedleaves can also be smoked as a joint, consumed in water pipes, or vaporized and
inhaled. Not regulated yet but DEA has listed Salvia as a drug of concern and isconsidering classifying it as a Schedule I drug, like LSD or marijuana.
Bath Salts newer fad, synthetic powders sold under names like Ivory Wave, Red Dove, Blue Silk,
Zoom often amphetamine-like chemicals, used orally, by inhalation, or injection, notyet well understood but linked to alarming number of ER visits across the country
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
11/118
Trends NSDUH April 2011 Report Overall underage (12-20) alcoholuse incl. binge drinking
showed gradual decline
12% of pop 12 & older (30.2 million) drove under the influenceof ETOH past yr. (down from 14.2 % in 2002)
Tobaccouse has declined; from 2002 to 2009, rate of past-month cigarette use fell from 13.0 percent to 8.9 percentamong 12- to 17-year-olds. Among young adults aged 18 to
25 years; rates of use fell from 40.8 percent in 2002 to 35.8percent in 2009
In 2010, 12th graders reported an annual prevalence rate of17% for hookahsmoking and 23% for the use of small cigars.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
12/118
Trends NSDUH April 2011 Report Dailymarijuanause increased among 8th, 10th, and 12th graders
from 2009 to 2010. Among 12th graders, use was at its highest
point since the early 1980s, at 6.1 percent. Perceived risk ofregular marijuana use also declined among 10th and 12th graders,suggesting future trends in use may continue upward.
Trends in lifetime use of amphetamineand methamphetamineindicate statistically significant declines from peak-year (1996) use
among high schoolers. Cocaineuse gradually declined between 2003 and 2009 among
people aged 12 or older (from 2.3 million to 1.6 million).
From 2009 to 2010, lifetime use of ecstasyamong 8-10th gradersincreased from 2.2 percent to 3.3 percent
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
13/118
Trends NSDUH April 2011 Report Rates of hallucinogenuse remained unchanged from 2009 to
2010, although significant increases were reported by 12th
graders for annual and past-month use of LSD. Past-year use of inhalantsalso remained steady from 2009 to
2010 with 8% of 8th graders reporting past-year use.
Prescriptionand OTC medications accounted for most of thetop drugs abused by 12th graders in the past year.
Nonmedical use of Vicodin decreased from 9.7% to 8.0%however, nonmedical use of Oxycontin remained unchanged,& has increased among 10th graders over the past 5 years.Nonmedical use of Adderall and OTC cough and cold medsremained high at 6.5 percent and 6.6 percent, respectively.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
14/118
National Data The annual total estimated societal cost of substance abuse in
the United States is $510.8 billion
In 2009, an estimated 23.5 million Americans aged 12 and olderneeded treatment for substance use
Half of all lifetime cases of mental and substance use disordersbegin by age 14 and three-fourths by age 24
Source: Substance Abuse and Mental Health Services Administration,Leading Change: A Plan for SAMHSAs Roles and Actions 2011-2014
Executive Summary and Introduction. HHS Publication No. (SMA) 11-
4629 Summary. Rockville, MD: Substance Abuse and Mental Health
Services Administration, 2011.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
15/118
Trends in West Virginia Spice Not the community, (synth et ic cannabinoids), & regular marijuana
Bath Salts DOPE not SOAP (Synthet ic cath inones)West Virginiais hoping to curb synthetic drug use with a ban. The legislature has approved a bill thatwould make buying, selling or possessing synthetic drugs illegal. The move came afterthe state's poison control center reported 80 cases of people using bath salts to get highsince the start of 2011. That's compared to three in all of 2010. (WTAP News, 3/19/2011)
Public confusion As evidenced by public comments on above article
Pain meds/pill mills Growing problem of illegal sales of Rx drugs-Significantopioid research at WVU
Methamphetamine pockets of abuse (DEA data)
Gambling
Health disparities plus access & capacity issues,stigma, poverty
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
16/118
Meth Notes rebounding after decline rural areas experiencing greater
increases in use availability on the rise smurfing and shake & bakecontribute to this 19.3 = average age of initiation, need prevention & treatment
resources!
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
17/118
From the Governors desk in Coal Valley News, April 3, 2012
Drug overdoses now kill more West Virginians thancar accidents
Drugs are the leading cause of accidental deaths inour state
We have the nations highest rate of drug deaths
9 out of 10 of our overdose deaths involve at leastone prescription drug http://www.coalvalleynews.com/view/full_story/18083312/articl
e-FIGHTING-DRUG-ABUSE-IN-WEST-VIRGINIA
http://en.wikipedia.org/wiki/File:Seal_of_West_Virginia.svghttp://en.wikipedia.org/wiki/File:Seal_of_West_Virginia.svg -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
18/118
Illicit Drug Dependence Past Year Persons Aged 12 & Older in WV
Source: SAMHSA, Office of Applied Studies, NationalSurvey on Drug Use and Health, 2006, 2007, and 2008.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
19/118
Nonmedical Use of Pain Relievers Persons Aged 12 or Older in WV
Source: SAMHSA, Office of Applied Studies, National Surveyon Drug Use and Health, 2006, 2007, and 2008.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
20/118
Alcohol Use Past Month among Persons Aged 12 -20 in WV
Source: SAMHSA, Office of Applied Studies, National Survey onDrug Use and Health, 2006, 2007, and 2008.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
21/118
Needing but Not Receiving Treatment for Drug Use Past
Year Persons 12 & Older in West Virginia
Source: SAMHSA, Office of Applied Studies, National Surveyon Drug Use and Health, 2006, 2007, and 2008.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
22/118
DSM-V Revisions reflect
major change!
Here is your resource to
follow the progress:http://www.dsm5.org/Pages/D
efault.aspx
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
23/118
DSM-Vhttp://www.dsm5.org/Pages/Default.aspx
Proposed changes affecting former
Dx of substance abuseand dependence Coming out May 2013
Field trials underway in large academic-medical settings and small solo/grouppractices
Two previous comment periods; third andfinal planned for spring 2012
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
24/118
Substance Use & Addictive Disorders
(formerly Substance-Related Disorders)
Substance Use Disorders
Substance Intoxication Substance Withdrawal
Gambling Disorder
Non-substance addictions recommended for inclusionthis moved from Impulse Control Disorders, NOS
Substance Induced Disorders
Also to be listed in chapter with disorder
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
25/118
R 00-10 Substance Use Disorders
R Substance Use DisorderR 00 Alcohol Use DisorderR 01 Amphetamine UseDisorderR 02 Cannabis Use DisorderR 03 Cocaine Use DisorderR 04 Hallucinogen Use Disorder
R 05 Inhalant Use Disorder
R 06 Opioid Use Disorder
R 07 Phencyclidine Use
DisorderR 08 Sedative, Hypnotic, or
Anxiolytic Use Disorder
R 09 Tobacco Use Disorder
R 10 Other (or Unknown)Substance Use Disorder
http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=431http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=452http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=454http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=455http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=456http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=459http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=459http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=456http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=455http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=454http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=452http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=431 -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
26/118
SUD Definition A maladaptive pattern of substance use leading to clinically
significant impairment or distress, as manifested by 2 (or
more) of the following, occurring within a 12-month period: recurrent substance use resulting in a failure to fulfill major role
obligations
recurrent substance use in situations in which it is physicallyhazardous
continued substance use despite having persistentor recurrent social or interpersonal problems
Tolerance
Withdrawal
to # 11
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
27/118
Specifiers
Severitymoderate to severe
With/without physiological dependence
Courseearly full remission, earlypartial, sustained full, sustained partial,on agonist therapy, in controlledenvironment
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
28/118
Why they got rid of abuseProblems identified with the DSM-IV division between
abuse and dependence led to many studies of the
structure of the abuse and dependence in a varietyof general population and clinical settings. Giventhe empirical evidence, the DSM-5 Substance UseDisorders Workgroup recommends combining
abuse and dependence into a single disorder ofgraded clinical severity, with two criteria required tomake a diagnosis.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
29/118
Substance IntoxicationR 11-21 Substance
Intoxication
R 11 Alcohol IntoxicationR 12 Amphetamine
Intoxication
R 13 Caffeine Intoxication
R 14 Cannabis Intoxication
R 15 Cocaine Intoxication
R 16 Hallucinogen Intoxication
R 17 Inhalant Intoxication
R 18 Opioid IntoxicationR 19 Phencyclidine Intoxication
R 20 Sedative, Hypnotic, orAnxiolytic IntoxicationR
21 Other (or Unknown) SubstanceIntoxication
http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=248http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=37http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=276http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=283http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=294http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=304http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=328http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=328http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=304http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=294http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=283http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=276http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=37http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=248 -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
30/118
Substance Withdrawal
R 22-30 SubstanceWithdrawal
R 22 Alcohol Withdrawal
R 23 AmphetamineWithdrawal
R 24 Caffeine Withdrawal
R 25 Cannabis Withdrawal
R 26 Cocaine Withdrawal
R 27 Opioid Withdrawal
R 28 Sedative, Hypnotic, orAnxiolytic Withdrawal
R 29 Tobacco Withdrawal
R 30 Other (or Unknown)Substance Withdrawal
http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=249http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=553http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=430http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=284http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=313http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=313http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=284http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=430http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=553http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=249 -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
31/118
Substance-Induced Disorders Substance-Induced Psychotic
Disorder
Substance-Induced BipolarDisorder
Substance-Induced DepressiveDisorder
Substance-Induced AnxietyDisorder
Substance-Induced Obsessive-Compulsive or RelatedDisorders
Substance-Induced Dissociative
Disorder
Substance-Induced Sleep-Wake Disorder
Substance-Induced SexualDysfunction
Substance-Induced Delirium
Mild Neurocognitive DisorderAssociated with Substance
Use Major Neurocognitive
Disorder Associated withSubstance Use
http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268 -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
32/118
Whats new? Changes in the addictions field
Definitions
Research
Laws
Services
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
33/118
What is addiction?
-ASAM August 2011:
Addiction is a primary, chronic disease
of brain reward, motivation, memoryand related circuitry- characterized by inability to consistently abstain,
impairment in behavioral control, craving, diminished
recognition of significant problems with ones behaviors
and interpersonal relationships, and a dysfunctionalemotional response
ASAMs full public policy statement may be found here:
http://www.asam.org/research-treatment/definition-of-addiction
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
34/118
Bringing the
Full Power of Scienceto Bear on
Drug Abuse& Addiction
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
35/118
Your Brain on Drugs in the 1980s
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
36/118
Your Brain on Drugs Today
YELLOW
shows places inbrain where
cocaine binds
(e.g., striatum)
Fowler et al., Synapse, 1989.
Addiction I s A Developmental Disease
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
37/118
National Epidemiologic Survey on Alcohol and Related Condi tions, 2003.
Age
0.0%0.0%
0.2%0.2%
0.4%0.4%
0.6%0.6%
0.8%0.8%
1.0%1.0%
1.2%1.2%
1.4%1.4%
1.6%1.6%
1.8%1.8%
55 1010 1515 2121 2525 3030 3535 4040 4545 5050 5555 6060 6565
%ineachagegroupwho
developfirst-time
dependence
CANNABISALCOHOL
TOBACCO
Addiction I s A Developmental Disease
that star ts in adolescence and childhood
Age at tobacco, alcohol, and cannabisdependence per DSM IV
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
38/118
Addiction is L ike Other Diseases
it is preventable, it is treatable, it changes biology,if untreated, it can last a lifetime
Healthy Brain Diseased Heart
Decreased Heart Metabolismin Heart Disease Patient
Decreased Brain MetabolisminDrug Addicted Patient
Diseased Brain/
Cocaine Addicted
Healthy
Heart
High
Low
Research supported by NIDA addresses all of thesecomponents of addiction.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
39/118
Addiction is a Chronicillness & public health issue
With similar characteristics,
including relapse rates, to
other chronic illnesses
Substance use disorders
should be insured,
monitored, treated and
evaluated like other chronicdiseases
McLellan AT, Lewis DC, et al.JAMA 2000; 284:1689-1695.
Hypertension
Diabetes
Asthma
Addiction
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
40/118
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
41/118
Addiction is Similar to Other Chronic I l lnesses Because:
It has biological and behavioral components, both of which mustbe addressed during treatment.
Recovery from it--protracted abstinence and restoredfunctioning--is often a long-term process requiring repeatedepisodes of treatment.
Relapses can occur during or after treatment, and signal a need
for treatment adjustment or reinstatement.
Participation in support programs during and followingtreatment can be helpful in sustaining long-term recovery
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
42/118
What is recovery?
SAMHSA , December 2011
Recovery from Mental Disorders and
Substance Use Disorders:
A process of change through which
individuals improve their health andwellness, live a self-directed life, andstrive to reach their full potential.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
43/118
Through the Recovery Support Strategic Initiative, SAMHSA hasdelineated four major dimensions that support a life in recovery:
http://blog.samhsa.gov/2011/12/22/samhsa%E2%80%99s-definition-and-guiding-principles-of-recovery-%E2%80%93-answering-the-call-for-feedback/
Health: overcoming or managing ones disease(s) as
well as living in a physically and emotionally healthy way;Home:a stable and safe place to live;Purpose:meaningful daily activities, such as a job,
school, volunteerism, family caretaking, or creativeendeavors, and the independence, income and resources
to participate in society; andCommuni ty: relationships and social networks that
provide support, friendship, love, and hope.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
44/118
How many people in the US are in recovery?
Best data wehave suggest
20 to 40 million
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
45/118
Emerging science of recovery Why do people seek recovery?
What are the benefits of recovery?
What do typical addiction careers look like?
How many people drop out before completing Tx?Why?
Could we have done anything so they would stayand complete? If so, what?
What is most important to support long-termrecovery?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
46/118
Typical addiction career
Number of abstinent periods one month or longer followed by return to druguse (prior to current abstinence & outside of a controlled environment)
20 & over
10%
Ten to 19
17%
Six to nine
7%
Four to five16%
Three11%
Two
22%
One
17%
50% reported 4 or more abstinent periods followed by return to active addiction
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
47/118
Typical treatment career
None21
One15
Two12
Three-four17
Five to nine21
Ten +14
Over half of outpatient clients have had
3 or more previous episodes
Laudet, Stanick & Sands, Eval Review, 2007
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
48/118
National average Tx completion rate for outpatientmodalities = 36%
Completed40
Left beforecompletion
60
NYC Outpatient treatment outcome
Laudet, Stanick, & Sands, JSAT 2009
f
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
49/118
Reasons for leaving treatment
Qualitative analyses:What is the most important reason why you dropped out of the program? *
8.5
9.4
12
12
12
12
18.8
31.6%
0 5 10 15 20 25 30 35
Not helpful
Finances
Do not want help
Family/personal issues
Convenience (e.g.,
transport)
Using
Tx interferes w/other
activity (e.g., job)
Dislike
program/staff/clients
* Add to > 100% because up to 2 answers were coded;
Laudet, Stanick, & Sands, JSAT 2009, 37:182-190
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
50/118
Minimizing attrition: What could have been d one di f ferent ly so that youwould have cont inued at tending (among yes)?
Practicalassistance
11 Help with otherareas of
functioning18
Better, morecaring staff25
Betterindividualized
services23
Greater flexibilityin scheduling23
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
51/118
Promoting abstinence alone is not enough
0 10 20 30 40 50Complete tx
Get life together
Relation w.family
Housing
Get kids back
Educ/Voc/Training
Get a job
Get/Stay clean
Abstinence is top goal but not only
goal!!
Asked at outpatient admission (N=314): What are the top
pr ior i t ies in yo ur l i fe right now?
However Extended Abstinence
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
52/118
HoweverExtended Abstinenceis Predictive of Sustained Recovery
It takes a year
of abstinence
before less thanhalf relapse
Dennis et al, Eval Rev, 2007
After 5 yearsif you are sober,
you probably will stay that way.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
53/118
Sources of support in long-term recovery
7
11
17
18
43
53
53%
0 10 20 30 40 50 60Clinici
ansFrien
dsSelf/innerstreng
thSpo
useRecove
ringpee
rsFam
ilySpirituality
/faith
N = 52 CCAR Membersmedian abstinence duration = 12 years
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
54/118
The mere action of making wellness
a bona fide outcome will reinforce the
fact that recovery from addiction is areality for many. By extension, this
can give hope to the many individualsand families affected by SUDs andsupport them in their search for the
solution that will work for them.Laudet, 2009
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
55/118
What else is driving change? Affordable Care Act and Parity Law
More people covered More services in primary care
settings
Large number of people
with SUDs still will nothave coverage
SAPT Block Grant
Distribution of Substance Use Problems
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
56/118
Severe
Substantial
Moderate
Mild
None
Alcohol, Illicit and Non-Prescribed Drugs
2.3 Million Specialty Treatment
~23 Million Addiction Dxfor comparison Diabetes~24 million
Harmful Use Dx ~60 Million
(SBIRTnow covered)
(Rawson, & Freese), (McLellan)
Little or no use
(Preventionnow covered)
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
57/118
Screening, Brief Intervention A single event can influence individuals
to reduce substance use for up to a year
May reduce mortalityrates by ~ 25%
Significantly reducessubstance-related accidentsand hospital visits
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
58/118
http://www.drugabuse.gov/nmassist/
Distribution of Funding
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
59/118
Medical
System
SUD
services
Residential
Outpatient
Detox
MAT
Block Grant
Medicaid
Insurance
Self pay
CurrentFundingSources
Tx System
Block Grant
Medicaid
Insurance
Self pay
HCRFundingSources
Recovery
Support
Distribution of Funding
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
60/118
HEALTH CARE REFORM
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
61/118
ROS, HCR & Integrated CareIn March 2010, President Obama signed
into law the Patient Protection and
Affordable Care Act and the
Health Care and Education
Reconciliation Act of 2010-from SAMHSA website
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
62/118
Overarching goals of health reform
Make health care more
1) accessible
2) affordable
3) efficient, and
4) effective
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
63/118
Key strategies in 4 major areas: Coverage expansion
Cant deny people for pre-existing conditions, or charge higher premiums basedon health status, caps on coverage, dropping people when they get sick, expands
Medicaid eligibility, requires coverage beg. 2014
Insurance reform Wellstone/Domenici Parity Act removes limits on coverage that do not apply to
other physical ailments , states will have Insurance Exchanges that includesubsidized plans, basic required benefits, including MH/SUD services at parity
Delivery system redesign (integration, chronicillness management, health homes),and
Payment reform
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
64/118
Prevention will be huge Including within chronic disease initiatives
Co-payments removed from screening for
depression, substance misuse,smoking cessation
Prevention & Public HealthFund will support EBPs for
programs that foster health,e.g. smoking cessation andcombating obesity.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
65/118
Numbers 32 million more Americans expected to be
insured by 2014
Of these, 20-30% will have MH and/or SUDs
Increased screening will raise demand forbrief and specialty MH/SUD treatment
Those with the most serious MH/SUDs aretwice as likely to be unemployed andtherefore still uninsured
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
66/118
Anticipated need for BH workforce
HCR has broad
implications for the
behavioral healthworkforce, not just in
terms of capacity, but
related to need for
training and education
to fulfill shifting or
new roles
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
67/118
Impact of ACA on BH WorkersCoverage Expansion
More peoplegain health carecoverage withparity
20-30%will haveMH/SUD
Morescreening
willidentifyeven morepeople
We willneed anexpanded
AND moreefficientworkforce
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
68/118
Impact of ACA on BH WorkersWorkforce Development
In order to improve patient satisfaction and healthoutcomes, Title V of the legislation includes
scholarship and loan programs For work in underserved areas, schools For skills development in EBPs, cultural
competence, C&A services
DOL defines SUD as a distressed
profession, i.e. lacking sufficientworkforce to meet public need Plan to recruit &train 60,000 new counselors over next
decade (depending on funding)
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
69/118
Impact of ACA on BH WorkersBilling, Block Grants
We dont know more than we know
about a lot of how things will play outMcLellan
Level and use of block grantfunding will be impacted by whois/isnt covered and gaps that
remain as more people gain coverage
Organizations not proficient in billing mayneed to learn about billing models for HCR
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
70/118
Impact of ACA on BH WorkersService Integration
Behavioral Health and Primary Care
By some estimates willreduce overall health carecosts by30% = $700 billion/year
While improvingquality of care
This report is available online athttp://www.nachc.com/research-data.cfm.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
71/118
Federal, state, local partners ACA is federal law, however states will
decide much about how it is enacted
Health exchanges, coverage for SUDs,billable services (licensed?, certified?, peers?)
All health care is local Community partnerships, what linkages make
sense, PC sites using SBI, who provides MAT,organizations involved in developing ROSmay be ahead of the curve
THOUGHTS
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
72/118
The work of HCR is just beginning; we will
learn as we go The future of the behavioral healthworkforce, including SUD services can bedecided in large part by how well preparedwe are
Our profession has a track record ofevolving to meet the demand for services
THOUGHTS
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
73/118
Partnering FQHCsFederally Qualified Health Centers are
safety net providers for underserved populations
141 in WV, 132 in VA (from HRSA Data Warehouse) With Medicaid expansion & funding for new
sites, target is to double patients served to 40million by 2015
Likely sites to be Health Homes If youve seen one FQHC, youve seen one great variability among areas, pop. Served, etc.
http://findahealthcenter.hrsa.gov/
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
74/118
A few of the Health Centers in West Virginia
Pineville Childrens Center
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
75/118
Growth of new types of services
focused on recovery
And recovery-or iented serv ices In formed by sc ience
Recovery management - key
Cultural change Advocacy
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
76/118
Recovery Model Acute Care Model
White (2008) Recovery Management &
Recovery-Oriented Systems of Care: Scientif ic
Rational & Promis ing Practices
Substance Abusing Patient
Non-Substance Abusing Patient
Treatment
Therapies,
Meds,
JCAHO,
CARF, EBPs,
etc.
Adapted from presentation by Tom McLellan, Ph.D.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
77/118
Shifting to a recovery-focused model means
...shifting theemphasis of
treatment from briefbiopsychosocialstabilization to one
of sustainedrecoverymanagement
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
78/118
Recovery Management includes pre-recovery support services to enhance
recovery readiness,
in-treatment recoverysupport services toenhance the strengthand stability of recovery
initiation, and post-treatment recovery support services to
enhance the durability and quality of recoverymaintenance.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
79/118
RM also includes Emphasis on resilience and recovery
processes (asopposed to pathologyand disease processes),
Recognition ofmultiple long-termpathways and styles of recovery,
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
80/118
Examples of pathways to recovery
Mutual support groupsAA, NA, Al-Anon, SOS, etc.
Professional treatment
inpatient, outpatient, etc.
Recovery Community OrganizationsSAARA of Virginia
Faith-based support services
Celebrate Recovery, etc.
Medication-assisted recoverymethadone, buprenorphine, etc.
Justice system programs
drug courts, TCs, etc.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
81/118
Recovery capital; problem severity, treatment failures and otherreframes
Recovery capital (RC) isthe breadth and depth of internal andexternal resources that can be drawnupon to initiate and sustain recoveryfrom severe alcohol and other drugproblems White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
82/118
Types of recovery capital Personal RC - can be
Physical, e.g. health, financial assets,
insurance, safe housing, etc., or
Human, e.g. values, knowledge,educational/vocational skills, credentials,
problem-solving skills, self-esteem,hopefulness, sense of purpose,interpersonal skills
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
83/118
Types of recovery capital
Family and social RC - intimaterelationships, family and kinship relationships(defined here non-traditionally, i.e., family of choice), and socialrelationships that are supportive of recovery efforts.Family/social recovery capital is indicated by willingness ofpartners and family members to participate in treatment, thepresence of others in recovery within the family and social
network, access to sober outlets for sobriety-basedfellowship/leisure, and relational connections to conventionalinstitutions (school, workplace, church, and other communityorganizations).
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
84/118
Types of recovery capital
Community RC - encompassescommunity attitudes/policies/resources related to addiction and
recovery that promote the resolution of alcohol and other drugproblems. Community recovery capital includes:
active efforts to reduce addiction/recovery-related stigma,
visible and diverse local recovery role models,
a full continuum of addiction treatment/recovery resources,
recovery mutual aid resources that are accessible and diverse, local recovery community support institutions (recovery centers,
recovery homes, etc. and
sources of sustained recovery support and early re-intervention
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
85/118
Early scientific findings Recovery capitalboth its quantity and quality
plays a major role in determining the success or
failure of natural and assisted recovery (e.g.,recovery from AOD problems without or withparticipation in professional treatment or a recoverymutual aid society)
Increases in recovery capital can spark turningpoints that end addiction careers, and triggerrecovery initiation
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
86/118
Early scientific findings
Such turning points often result after several yearsand multiple episodes of professional treatments
Recovery capital is not equally distributedacross individuals and social groups. Members ofhistorically disempowered groups often seekrecovery from addiction lacking assets that aretaken for granted by those seeking recovery from aposition of privilege White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
87/118
Early scientific findings
Most clients with severely depleted
family and community recovery capital gain littlefrom individually-focused addiction treatment thatfails to mobilize family and community resources
Long-term recovery outcomes for those with the
most severe AOD problems may have more to dowith family and community recovery capital than aparticular treatment protocol
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
88/118
The concept of recovery capital
reflects a shift in focus from the
pathology of addiction to a focus onthe internal and external assetsrequired to initiate and sustain long-term recovery from alcohol and other
drug problems.
White & Cloud, 2008
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
89/118
Federal Initiatives to support ROSAddiction Technology Transfer Center (ATTC) Network
SAMHSA/CSAT funds a network of 14 regional
ATTCs, which provide training and technicalassistance to states. The ATTC network publishesguides, toolkits and monographs supportingtreatment and recovery systems and services.These include numerous publications on recovery-specific topics. Each of the ATTCs has establisheda ROSC implementation support team to assiststates in implementing ROSC.
http://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asp -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
90/118
Federal Initiatives to support ROSAccess to Recovery (ATR)
(ATR)is a Substance Abuse and Mental Health
Services Administration (SAMHSA) programwhich awards competitive grants to states andtribes to implement voucher systems forpurchasing substance use disorder treatmentand recovery support services. ATR providesstates and tribes with an excellent mechanismfor developing systems and services that moreeffectively support long-term recovery.
http://www.atr.samhsa.gov/http://www.nattc.org/learn/topics/rosc/rss.asphttp://www.nattc.org/learn/topics/rosc/rss.asphttp://www.atr.samhsa.gov/ -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
91/118
Federal Initiatives to support ROS Recovery Community Services Program (RCSP)
The Recovery Community Services Program is a SAMHSA grant programwhich funds organizations to provide peer-to-peer recovery support services
for people in or seeking recovery from alcohol and drug problems. Initiatedin 1998, RCSP has seeded the development of numerous recoverycommunity organizations.
Targeted Capacity Expansion-Local Recovery-Oriented
Systems of Care (TCE-ROSC)
SAMHSAs Targeted Capacity of Expansion (TCE) Local Recovery-Oriented Systems of Care (TCE-Local ROSC) grants assist in thedevelopment of Recovery-oriented Systems of Care (ROSC) at alocal level.
BRSS TACS Bringing Recovery Supports to Scale - current
http://www.samhsa.gov/grants/2011/ti_11_004.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2011/ti_11_004.aspx -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
92/118
Federal Initiatives to support ROS Partners for Recovery (PFR)
Partners for Recoveryis a SAMHSAinitiative that supports the developmentof recovery-oriented policy, systems andservices. It engages diversestakeholders including Federal agencies,states, tribes, local governments,professional/ trade associations, faith-
based groups, health care professionals,nurses, social workers, and recoverysupport services providers to accomplishthis.
http://www.pfr.samhsa.gov/http://www.pfr.samhsa.gov/ -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
93/118
ROS Implementation challenges Need for more sciencewe still know comparatively
little from the standpoint of science about the prevalence, pathways,and styles of long-term recovery
Integration of professionally directedservices and peer-based recovery supportwho best to provide, where are the boundaries andethical guidelines
Service capacitieshow ought resources to bereallocated and how does this affect service capacity
White, Kurtz, Sanders, 2006
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
94/118
ROS Implementation challenges
Historical and conceptual momentumwe are steeped in the acute care model, # days or sessions,continuing care almost non-existent
Reimbursement and regulationsallbased on the acute model
High staff turnoverin theworkforce precludes continuity of contact
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
95/118
Recovery Community Organizations have grown andpaved a way forward one example:
Founded 1997
RCSP and state grants, consistentlyincreased grant funding, regular
state funding Huge face on recovery
Huge advocacy presence
Multiple Recovery CommunityCenter sites
Recovery housing network
Recovery Coach training program
Product development
National leader for partnering withstate systemshttp://www.ccar.us/default.htm
http://www.ccar.us/default.htmhttp://www.ccar.us/default.htm -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
96/118
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
97/118
Virginias Statewide RCO
Substance Abuse and Addiction Recovery Alliancehttp://www.saara.org/
SAARA of Virginia is a grassroots recovery community organization. All friends ofrecovery are invited and welcome to join. Our members include individuals inrecovery from alcohol and other drug addiction, their families, friends, anddedicated community supporters. Across the Commonwealth of Virginia, weare seventeen affiliates strong and growing. SAARA promotes social,
educational, legal, research and health care resources and services thatsupport accessible, effective and accountable addiction prevention,intervention, treatment and Recovery. We envision the day when the stigma ofaddiction will be eradicated, and all who seek recovery will find it. Recoveryhappens! Please take a look around our website and let us know if you haveany comments or questions.
http://www.saara.org/http://www.saara.org/ -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
98/118
RCOs can foster ROS in systems By providing service coordination and
modeling person-centered, strengths-
based services
By putting a face onrecovery
By supporting multiplepathways to recovery
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
99/118
RCOs can foster ROS in systems
By providing recovery coaching and
assertive linkages to communities ofrecovery
By supporting recovery
housing
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
100/118
RCOs can foster ROS in systems By encouraging hope & optimism about
recovery through peers
By addressing stigma
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
101/118
RCOs can foster ROS in systems By focusing on and modeling
strategies for engagement andmotivational enhancement
This
This
NOT
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
102/118
ROS Outcomes: System Numbers Philadelphia
36% in crisis utilization after 1 year
50% cost of inpatient psychiatric services Connecticut
46% in number of people served statewide
62% in use of acute care
40% in outpatient care
25% in annual cost per client
Outcomes: Individuals Seeking RecoverySAARA Center for Recovery in Virginia
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
103/118
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
104/118
Recovery Oriented Services
Have a growing evidence base for theireffectiveness
Fit perfectly into the prioritiesfor HCR
Include lower-cost
interventionsfor disease/recoverymanagement
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
105/118
Addiction is visible everywhere in thisculture, but the transformative power of
recovery is hidden behind closed doors. Itis time we all became recovery carriers. Itis time we helped our community, ournation, and our world recover Recovery
is contagious. Get close to it. Stay closeto it. Catch it. Keep catching it. Pass iton. (White, 2010)
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
106/118
Where shall we go, what shall we do, and how canyou help? Implications for clinical practice
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
107/118
Stigma
New definitions ofaddiction, recoverybased on science
Chronic vs. acute illness modelnew
services, peer providers DSM-5
Other?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
108/118
A study of stigmatized attitudes towards people with mentalhealth problems among health professionals.
In J Psychiatr Ment Health Nurs. 2009 Apr;16(3):279-84.
Summary: 108 health professionals from acute and
mental health settings completed questionnaires.Participants had highly stigmatized attitudestowards patients with active substance usedisorders. Attitudes were less stigmatized to people
with SUDs who wererecovering/in remission.
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
109/118
The effectiveness of interventions for reducing stigma relatedto substance use disorders: a systematic review.
Addiction. 2012 January; 107(1): 3950.
Summary: Effective strategies foraddressing social stigma include
communicating positive stories ofpeople with substance use disorders.For changing stigma at a structurallevel, contact-based training andeducation programs targeting
medical students, clinical and otherprofessionals (e.g. police) areeffective.
Hello, my nameis Tara and I am
in long-termrecovery which
means
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
110/118
Implications of the above for clinical practice
Stigma of addictions
What is our responsibility for our own andothers professional attitudes?
What is our responsibility for communityeducation to fight stigma?
What, if any, is the responsibility ofrecovering professionals/others toadvocate?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
111/118
Do you think our services system as it exists today reflectsthe new, more broad definition of recovery? How/How not?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
112/118
The future of addiction treatment hinges on our ability toconnect treatment with recovery!
The emerging science of recovery supports
extending the acute care model to a model of
recovery-oriented services that supportssustained recovery management
Several states, communities and treatment
organizations have begun to
transform their systems Models for recovery management
are already working
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
113/118
Implications for clinical practice What do clinicians need to know about
recovery management/chronic care?
Do clinicians have a role in systemschange toward recovery-orientedservices and systems?
Other?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
114/118
DSM-5, etc. implications for clinical practice
What is clinicians responsibility re: the
new DSM? Offering feedback?
How can clinicians prepare for greaterintegration of behavioral health andprimary care?
What other implications can you thinkof from our discussion today?
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
115/118
New environments, new challenges, new options
-
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
116/118
http://www.williamwhitepapers.com/books_monographs/ -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
117/118
http://www.williamwhitepapers.com/
http://www.williamwhitepapers.com/books_monographs/http://www.williamwhitepapers.com/books_monographs/ -
8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf
118/118